Jennifer Porter

A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone

M. Carducci, M. Eisenberger, C. Sweeney, 2010, Cancer Chemotherapy and Pharmacology.